Financials Tivic Health Systems, Inc.

Equities

TIVC

US8887052095

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:30:00 2024-04-26 pm EDT 5-day change 1st Jan Change
1.04 USD -2.80% Intraday chart for Tivic Health Systems, Inc. -6.31% -42.22%

Valuation

Fiscal Period: December 2021 2022 2023
Capitalization 1 37.69 6.193 2.639
Enterprise Value (EV) 1 25.43 3.206 -0.387
P/E ratio -1.6 x -0.61 x -0.17 x
Yield - - -
Capitalization / Revenue 32.3 x 3.37 x 2.24 x
EV / Revenue 21.8 x 1.74 x -0.33 x
EV / EBITDA -4.52 x -0.32 x 0.05 x
EV / FCF -6,561,423 x -575,928 x 80,748 x
FCF Yield -0% -0% 0%
Price to Book 2.84 x 1.71 x 0.74 x
Nbr of stocks (in thousands) 97.2 96.8 1,466
Reference price 2 388.0 63.99 1.800
Announcement Date 3/31/22 3/31/23 3/25/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023
Net sales 1 0.42 0.86 1.166 1.84 1.176
EBITDA 1 -3.639 -3.196 -5.624 -10.09 -8.237
EBIT 1 -3.643 -3.204 -5.632 -10.1 -8.245
Operating Margin -867.38% -372.56% -483.02% -548.8% -701.11%
Earnings before Tax (EBT) 1 -4.146 -3.639 -8.493 -10.1 -8.244
Net income 1 -4.148 -3.639 -8.494 -10.1 -8.244
Net margin -987.62% -423.14% -728.47% -548.7% -701.02%
EPS 2 -180.3 -158.0 -243.2 -104.4 -10.40
Free Cash Flow - -0.9739 -3.875 -5.566 -4.793
FCF margin - -113.24% -332.36% -302.51% -407.58%
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 5/14/21 5/14/21 3/31/22 3/31/23 3/25/24
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3
Net sales 1 0.528 0.477 0.408 0.376 0.161 0.282
EBITDA - - - - - -
EBIT - - - - - -
Operating Margin - - - - - -
Earnings before Tax (EBT) - - - - - -
Net income - - - - - -
Net margin - - - - - -
EPS - - - - - -
Dividend per Share - - - - - -
Announcement Date 8/15/22 11/14/22 3/31/23 5/15/23 8/14/23 11/14/23
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023
Net Debt 1 - - - - -
Net Cash position 1 2.31 0.87 12.3 2.99 3.03
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow - -0.97 -3.88 -5.57 -4.79
ROE (net income / shareholders' equity) - -610% -140% -119% -229%
ROA (Net income/ Total Assets) - -87.9% -42.5% -60.4% -93.4%
Assets 1 - 4.139 19.99 16.71 8.825
Book Value Per Share 2 103.0 -50.60 137.0 37.50 2.440
Cash Flow per Share 2 100.0 44.90 134.0 36.30 2.320
Capex 1 0.03 - - 0.01 0.12
Capex / Sales 7.38% - - 0.6% 10.03%
Announcement Date 5/14/21 5/14/21 3/31/22 3/31/23 3/25/24
1USD in Million2USD
Estimates
  1. Stock Market
  2. Equities
  3. TIVC Stock
  4. Financials Tivic Health Systems, Inc.